MedPath

Study on navauppu mezhugu in dysmenorrhoea

Recruiting
Conditions
Lower abdominal pain or pelvic pain during menstrual cycleBackache
Registration Number
CTRI/2017/06/008938
Lead Sponsor
Ayothidas pandithar hospital
Brief Summary

Dysmenorrhoea meanspainful menstruation of sufficient magnitude so as to incapacitate day to dayactivities. These patients can be divided into two groups for understanding thepathogenesis of this distressing condition. Navauppu mezhugu a classical siddhamedicine in siddha vaithiya thirattu is indicated for soodhaga vayu inparticular. The investigator has interpreted this soodhaga vayu as to beDysmenorrhoea and it is supported by the fact that this formulation is beingused in clinical practice by many traditional physicians.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Female
Target Recruitment
10
Inclusion Criteria
  1. Lower abdominal or pelvic pain during menstrual cycle 2) Functional pain scale 3-5 3) Backache.
Exclusion Criteria
  1. Any major systemic illness 2) Hypertension 3) Renal disorder 4) Malignant tumor 5) vulnerable group.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improved pain score reduced from 5-3 to 0-21) Total period – 1 1/2 years or till the completion of the study whichever is earlier | 2) Recruitment for the study will be for 1 year. | 3) Treatment duration for each patient- 12 days/4 cycles | 4) Follow up period after drug treatment for each patient -2 months | 5) Data entry analysis – 2 months | 6) Report preparation and submission – 2months
No improvement pain score not reduced below 31) Total period – 1 1/2 years or till the completion of the study whichever is earlier | 2) Recruitment for the study will be for 1 year. | 3) Treatment duration for each patient- 12 days/4 cycles | 4) Follow up period after drug treatment for each patient -2 months | 5) Data entry analysis – 2 months | 6) Report preparation and submission – 2months
Secondary Outcome Measures
NameTimeMethod
Complete clearance or reduction of size of uterine fibroids adenomyosis endometriosis ovarian cyst including associated symptomsNo clinical improvement

Trial Locations

Locations (1)

NATIONAL INSTITUTE OF SIDDHA

🇮🇳

Kancheepuram, TAMIL NADU, India

NATIONAL INSTITUTE OF SIDDHA
🇮🇳Kancheepuram, TAMIL NADU, India
SATHIYABAMA
Principal investigator
9489912041
dr.sathyabama27@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.